Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Classical hematology 1CNS 1

Conditions

Breast Neoplasms 109Neoplasms 99Lung Neoplasms 60Colorectal Neoplasms 45Prostatic Neoplasms 40Carcinoma, Non-Small-Cell Lung 39Pancreatic Neoplasms 33Melanoma 31Head and Neck Neoplasms 27Neoplastic Cells, Circulating 25Ovarian Neoplasms 24Uterine Cervical Neoplasms 20Sarcoma 19Multiple Myeloma 19Glioma 19Colonic Neoplasms 19Carcinoma, Hepatocellular 17Leukemia, Myeloid, Acute 16Neoplasm Metastasis 15Squamous Cell Carcinoma of Head and Neck 14Lymphoma 14Glioblastoma 14Esophageal Neoplasms 14Endometrial Neoplasms 14Leukemia 12Kidney Neoplasms 11Hematologic Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11Myelodysplastic Syndromes 10

Interventions

Sertraline 1Selective Serotonin Reuptake Inhibitors 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Fragile X Syndrome × Blood Specimen Collection × Clear all
NCT06147414 2026-04-23

DANNIgene

Assistance Publique - Hôpitaux de Paris

Recruiting
550 enrolled
CNSClassical hematologyGenitourinary

Hydrocephalus, X-linked, Neurofibromatosis-Noonan syndrome, Anemia, Sickle Cell, Hemophilia B, Cystic Fibrosis, Fragile X Syndrome, Hemophilia A, Huntington Disease, Myotonic Dystrophy, Polycystic Kidney, Autosomal Recessive, Neurofibromatoses, Muscular Dystrophy, Duchenne

Data powered by HemOnc (CC BY 4.0) Colophon âš¡